Cerium-Catalyzed, Aerobic Oxidative Synthesis of 1,2-Dioxane Derivatives
3.25 mmol) and β-diketone 6f (197 mg, 1.56 mmol) were converted [36 mg, 0.12 mmol, 7%, A/B = 53:47, Rf(SiO2, PE/EA, 5:1) = 0.28]
FULL PAPER
in 0.5 mL iPrOH according to the General Procedure B.
Chromatography (SiO2, PE/EA, 5:1) gave a first fraction with a
mixture of the title compounds 1a and 1c [90 mg, 0.34 mmol, 22%,
1a/1c 75:25, Rf(SiO2, PE/EA, 2:1) = 0.22] as a colorless solid, m.p.
102–105°C. The second fraction contained the 1,4-diketone 2f
(34 mg, 0.14 mmol, 9%) as yellowish oil. 1H NMR (500 MHz,
CDCl3), isomer 1a und 1c: δ = 1.34 (s, 3 H, CH3, isomer 1a), 1.75–
1.88 (m, 4 H), 1.89–1.95 (m, 2 H), 1.96–2.01 (m, 2 H), 2.08–2.15
(m, 1 H), 2.16–2.22 (m, 1 H), 2.21–2.37 (m, 4 H), 2.29 (s, 3 H,
was obtained as a colorless oil. The second fraction contained a
third isomer C [49 mg, 0.17 mmol, 11%, Rf(SiO2, PE/EA, 5:1) =
0.20] as colorless crystals. Single crystals were grown from isomer
1
C. Isomers A and B: H NMR (500 MHz, CDCl3): δ = 0.82 (t, J
= 7.6 Hz, 3 H, CH3, isomer B), 0.92 (t, J = 7.5 Hz, 3 H, CH3,
isomer A), 1.33 (t, J = 7.2 Hz, 3 H, CH3, isomer B), 1.38 (t, J =
7.2 Hz, 3 H, CH3, isomer A), 1.53 (s, 3 H, CH3, isomer B), 1.55–
1.61 (m, 1 H), 1.66–1.73 (m, 1 H), 1.70 (s, 3 H, CH3, isomer A),
1.92–2.02 (m, 3 H), 2.05–2.12 (m, 1 H), 2.39 (dd, J = 14.0, J =
CH3, isomer 1c), 2.46–2.52 (m, 2 H), 3.54 (br. s, 1 H, OH, isomer 2.5 Hz, 1 H, isomer B), 2.69 (dd, J = 14.1, J = 2.5 Hz, 1 H, isomer
1c), 4.28 (br. s, 1 H, OH, isomer 1c), 5.31 (dd, J = 11.4, J = 2.5 Hz, A), 3.53 (s, 1 H, OH, isomer B), 4.21–4.29 (m, 2 H, OCH2, isomer
1 H, CH, isomer 1c), 5.57 (dd, J = 11.7, J = 2.2 Hz, 1 H, CH, B), 4.29–4.42 (m, 2 H, OCH2, isomer A), 5.21 (dd, J = 11.7, J =
isomer 1a), 7.31–7.38 (m, 10 H, CH) ppm. 13C{1H} NMR
(125 MHz, CDCl3), isomer 1a: δ = 18.12 (CH2), 20.86 (CH3), 34.52
2.4 Hz, 1 H, CH, isomer A), 5.76 (dd, J = 11.6, J = 2.5 Hz, 1 H,
CH, isomer B), 7.17 (br. s, 1 H, OH, isomer A), 7.31–7.39 (m, 10
(CH2), 34.93 (CH2), 39.57 (CH2), 52.26 (C), 78.45 (CH), 100.21 H) ppm. 13C{1H} NMR (125 MHz, CDCl3), isomer A: δ = 8.87
(C), 127.14 (CH), 128.64 (CH), 128.92 (CH), 137.30 (C), 217.94 (CH3), 14.18 (CH3), 22.05 (CH3), 28.20 (CH2), 34.19 (CH2), 52.85
(C=O) ppm. Isomer 1c. δ = 19.03 (CH2), 27.17 (CH3), 30.58 (CH2),
33.07 (CH2), 35.36 (CH2), 57.44 (C), 77.26 (CH), 108.17 (C), 126.97
(CH), 128.60 (CH), 128.68 (CH), 137.57 (C), 211.67 (C=O) ppm.
(C), 61.94 (CH2), 81.19 (CH), 101.63 (C), 126.78 (CH), 128.65
(CH), 128.81 (CH), 138.14 (C), 176.34 (C=O) ppm. Isomer B: δ =
8.21 (CH3), 14.18 (CH3), 20.36 (CH3), 28.90 (CH2), 34.19 (CH2),
52.51 (C), 60.95 (CH2), 81.64 (CH), 104.53 (C), 126.96 (CH),
MS (FAB, glycerol): m/z (%) = 263 (9) [MH+], 245 (100) [M+
–
H2O], 229 (84) [M+ – H2O2], 203 (13), 187 (15), 151 (34), 105 (12). 128.65 (CH), 128.76 (CH), 137.49 (C), 172.98 (C=O) ppm. MS (EI,
IR (ATR): ν = 3385 (br. s), 1729 (vs), 1670 (vs), 1453 (m), 1376 70 eV): m/z (%) = 294 (2) [M+], 276 (3) [M+ – H2O], 262 (12) [M+
–
˜
(m), 1320 (m), 1272 (m), 1156 (s) cm–1. HRMS (CI, CH4): calcd. O2], 234 (19), 190 (8), 188 (29), 158 (53), 143 (19), 129 (32), 105
263.1283 (for C15H19O4), found 263.1280 [MH+].
(100), 77 (51). IR (ATR): ν = 3352 (br. m), 2976 (s), 2942 (m), 1724
˜
(vs), 1694 (vs), 1455 (s), 1371 (m), 1312 (m), 1234 (m), 1215 (s),
1196 (s), 1124 (m), 1036 (m) cm–1. C16H22O5 (294.34): calcd. C
65.29, H 7.53; found C 65.46, H 7.56. Isomer C: 1H NMR
(500 MHz, CDCl3): δ = 0.87 (t, J = 7.5 Hz, 3 H, CH3), 1.29 (t, J
= 7.1 Hz, 3 H, CH3), 1.58 (s, 3 H, CH3), 1.99–2.06 (m, 1 H), 2.06–
2.15 (m, 2 H), 2.73 (ddd, J = 14.8, J = 12.3, J = 1.3 Hz, 1 H), 3.50
(br. s, 1 H, OH), 4.15–4.27 (m, 2 H, CH2), 5.18 (dd, J = 12.3, J =
2.0 Hz, 1 H, CH), 7.33–7.42 (m, 5 H) ppm. 13C{1H} NMR
(125 MHz, CDCl3): δ = 9.02 (CH3), 14.18 (CH3), 20.94 (CH3),
23.70 (CH2), 29.65 (CH2), 52.17 (C), 61.16 (CH2), 78.83 (CH),
102.12 (C), 127.16 (CH), 128.64 (CH), 128.96 (CH), 137.40 (C),
173.02 (C=O) ppm. M.p. 89–92°C. C16H22O5 (294.34): calcd. C
65.29, H 7.53; found C 65.59, H 7.50.
7-Hydroxy-7-methyl-10-phenyl-8,9-dioxaspiro[5.5]undecane-1-one
(1b): CeCl3·7H2O (30 mg, 0.081 mmol), styrene (5) (333 mg,
3.20 mmol) and β-diketone 6o (226 mg, 1.55 mmol) were converted
in 0.5 mL iPrOH according to the General Procedure B.
Chromatography (SiO2, PE/EA, 5:1) gave the title compound 1b as
a mixture of diastereoisomers A and B [140 mg, 0.507 mmol, 33%;
A/B = 71:29, isomer A: Rf(SiO2, PE/EA, 2:1) = 0.38, isomer B:
Rf(SiO2, PE/EA, 2:1) = 0.42] as a colorless oil. Both isomers could
be separated by repeated chromatography. Isomer A: 1H NMR
(500 MHz, CDCl3): δ = 1.26 (qt, J = 13.6, J = 1.5 Hz, 1 H), 1.50
(qt, J = 13.5, J = 4.1 Hz, 1 H), 1.59–1.65 (m, 1 H), 1.66–1.72 (m,
1 H), 1.75–1.81 (m, 1 H), 1.84–1.88 (m, 1 H), 1.90–1.95 (m, 1 H),
2.11 (dt, J = 14.1, J = 5.1 Hz, 1 H), 2.22 (s, 3 H, CH3), 2.38 (dt, J
= 14.0, J = 3.6 Hz, 1 H), 2.51 (dd, J = 13.2, J = 11.8 Hz, 1 H),
4.22 (br. s, 1 H, OH), 5.46 (dd, J = 11.7, J = 2.5 Hz, 1 H, CH),
7.32–7.39 (m, 5 H) ppm. 13C{1H} NMR (125 MHz, CDCl3): δ =
22.24 (CH2), 22.79 (CH2), 26.14 (CH3), 30.36 (CH2), 34.58 (CH2),
36.02 (CH2), 53.38 (C), 78.22 (CH), 99.54 (C), 127.10 (CH), 128.68
Ethyl 6-Hydroxy-3-phenyl-4,5-dioxabicyclo[4.4.0]decane-1-carbox-
ylate (1e): CeCl3·7H2O (30 mg, 0.081 mmol), styrene (5) (331 mg,
3.18 mmol) and β-keto ester 6b (267 mg, 1.57 mmol) were con-
verted in 0.5 mL iPrOH according to the General Procedure B.
Chromatography (SiO2, PE/EA, 10:1) gave a mixture of two dia-
stereoisomers A and B (240 mg, 0.785 mmol, 50%, A/B = 50:50),
which were separated by repeated chromatography [isomer A:
Rf(SiO2, PE/EA, 5:1) = 0.32; isomer B: Rf(SiO2, PE/EA, 5:1) =
0.15]. Single crystals were grown from isomer A, m.p. 118°C.
C17H22O5 (306.15): calcd. C 66.65, H 7.24; found C 66.79, H 7.15.
All spectroscopic data were in accordance with the literature.[10b]
1
(CH), 129.01 (CH), 137.59 (C), 212.51 (C=O) ppm. Isomer B: H
NMR (500 MHz, CDCl3): δ = 1.60–1.74 (m, 4 H), 1.75–1.80 (m, 2
H), 1.87 (dq, J = 13.1, J = 4.6 Hz, 1 H), 2.25–2.29 (m, 1 H), 2.32
(s, 3 H, CH3), 2.41–2.54 (m, 1 H), 2.74 (dd, J = 14.7, J = 12.2 Hz,
1 H), 5.05 (dd, J = 12.0, J = 2.1 Hz, 1 H, CH), 7.16 (br. s, 1 H,
OH), 7.33–7.42 (m, 5 H) ppm. 13C{1H} NMR (125 MHz, CDCl3):
δ = 20.36 (CH2), 22.54 (CH2), 26.84 (CH3), 31.32 (CH2), 32.38
(CH2), 36.07 (CH2), 52.36 (C), 81.21 (CH), 104.19 (C), 126.75
(CH), 128.76 (CH), 129.00 (CH), 137.84 (C), 217.01 (C=O) ppm.
Methyl 7-Hydroxy-10-methyl-10-phenyl-8,9-dioxabicyclo[5.4.0]un-
decane-1-carboxylate (1f): CeCl3·7H2O (30 mg, 0.081 mmol), α-
methylstyrene (393 mg, 3.33 mmol) and β-keto ester 6c (291 mg,
1.71 mmol) were converted in 0.5 mL iPrOH according to the Ge-
neral Procedure B. Chromatography (SiO2, PE/EA, 10:1) gave a
mixture of four diastereoisomers A, B, C, and D (288 mg,
0.899 mmol, 53%, A/B/C/D = 38:25:24:16), which were partly sepa-
rated by repeated chromatography [isomer A and D: Rf(SiO2, PE/
MS (FAB, glycerol): m/z (%) = 277 (26) [MH+], 259 (100) [MH+
–
H2O], 243 (93) [MH+ – H2O2], 217 (16), 199 (20), 165 (29), 132
(56), 123 (40), 105 (26). IR (ATR): ν = 3322 (br. m), 2940 (s), 2868
˜
(m), 1685 (s), 1453 (s) cm–1. C16H20O4 (276.14): calcd. C 69.55, H
7.30; found C 69.66, H 7.28.
Ethyl 4-Ethyl-3-hydroxy-3-methyl-6-phenyl-1,2-dioxane-4-carboxyl-
ate (1d): CeCl3·7H2O (30 mg, 0.081 mmol), styrene (5) (333 mg, EA, 5:1) = 0.28; isomer B and C: Rf(SiO2, PE/EA, 5:1) = 0.34–
3.20 mmol) and β-keto ester 6j (261 mg, 1.65 mmol) were converted
in 0.5 mL iPrOH according to the General Procedure B.
Chromatography (SiO2, PE/EA, 10:1) gave two fractions with the
product. In the first a mixture of two diastereoisomers A and B
0.44]. Single crystals of isomer C were grown from a mixture with
isomer B, m.p. 124–129°C. C18H24O5 (320.38): calcd. C 67.48, H
7.55; found C 67.28, H 7.55. All spectroscopic data were in accord-
ance with the literature.[10b]
Eur. J. Org. Chem. 2005, 5031–5038
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5037